Projects

This section presents pharmaceutical projects that are announced from time-to-time around the world.

Curia Invests US$200 Million to Expand Facilities in the UK and USA

Curia is investing US$200 million to expand its sterile fillfinish facilities in Glasgow, UK, and Albuquerque, NM, USA

CordenPharma Constructs New Peptide Manufacturing Facility in Switzerland

CordenPharma is investing over US$540 million 500 million to construct a new peptide manufacturing facility in Muttenz, Switzerland The facility, located at Getec Park near Basel, is designed for small, medium, and largescale peptide production

NJEDA and Coriell Institute for Medical Research Invests US$41 million for State-of-the-Art Innovation Centre in UK

The New Jersey Economic Development Authority NJEDA and the Coriell Institute for Medical Research plan to invest US$41 million in the establishment of a stateoftheart Strategic Innovation Centre SIC in Camden

Endo Plans to Open New Manufacturing Facility in India

Endo, Inc announces its plans to open a new aseptic manufacturing facility in Indore, India This cuttingedge 20,000squarefoot facility is specifically designed for the aseptic manufacturing of sterile injectable products

Macsen Labs Group Plans for the Construction of New Manufacturing Facility in India

Macsen Labs Group has announced the commencement of construction of a new Active Pharmaceutical Ingredient API manufacturing facility in India

Novo Nordisk Invests US$1.18 billion (DKK 8.5 billion) for New Production Facility in Denmark

Novo Nordisk plans to invest US$118 billion DKK 85 billion in opening a cuttingedge production facility in Odense, Denmark

BioCentriq Invests US$12 million to Expand Cell Therapy Manufacturing Facility in USA

BioCentriq palns to invest a stateoftheart cell therapy manufacturing facility in New Jersey, USA

Indiana University Invests US$138 million for State-of-the-Art Bioscience Facility in USA

Indiana University palns to invest US$138 million to open a new stateoftheart facility in USA

Afton Scientific Invests US$200 million to Expand Biopharmaceutical Manufacturing Facility in USA

Afton Scientific plans to invest US$200 million to expand its biopharmaceutical manufacturing facility in Albemarle County, USA

FUJIFILM Diosynth Biotechnologies Unveils Global CDMO Ecosystem Expansion in Denmark

FUJIFILM Diosynth Biotechnologies is planning the first phase of its expansion at the Hillerd facility in Denmark